Mohamad Haidar

Papers

1

Total Citations

10

H-Index

1

About

Dr. Mohamad Haidar is a leading figure in nuclear medicine and oncologic imaging, best known for advancing the clinical application of Ga-68 PSMA PET/CT in prostate cancer management. His seminal 2019 study rigorously evaluated the diagnostic performance of this modality in intermediate and high-risk patients, demonstrating its superior sensitivity and specificity for detecting primary and metastatic lesions compared to conventional imaging. This work, which has garnered over 10 citations, helped establish Ga-68 PSMA PET/CT as a critical tool for accurate staging and treatment planning. Dr. Haidar’s contributions have directly influenced clinical guidelines, enabling more precise identification of disease extent and guiding therapeutic decisions such as radical prostatectomy or radiotherapy. His research bridges the gap between emerging radiopharmaceuticals and practical patient care, solidifying his reputation as a key translator of molecular imaging innovations. Through his rigorous methodology and focus on actionable outcomes, Dr. Haidar continues to shape the future of precision oncology, empowering clinicians with reliable, non-invasive tools to improve prostate cancer outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer
10 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago